Molbio Diagnostics Ltd Listed
Incorporated in October 2000, Molbio Diagnostics Limited is a global point-of-care (POC) molecular diagnostics company engaged in the research, development, manufacturing, and commercialization of rapid diagnostic...
GREY MARKET PREMIUM
+₹132
▲ +16.36% vs issue price
Issue Price
₹807.00
Est. Listing Price
₹939.00
Lot Size
18
Issue Details
Open Date
2026-08-10
Close Date
2026-08-12
Allotment
2026-08-13
Face Value
₹1.00
Total Issue Size
1,16,46,246 shares (agg. up to ₹940 Cr) Cr
Issue Type
Bookbuilding IPO
Exchange
NSE & BSE
Subscription Status
| Category | Subscription (x) | Shares Offered | Shares Bid |
|---|---|---|---|
| QIB | 75.13x | 5812862.00 | 436729734.00 |
| NII (HNI) | 49.62x | 1743860.00 | 86532732.00 |
| Retail | 12.65x | 4069005.00 | 51466284.00 |
| Market Maker | 1x | - | - |
| Total | 1.95x | 20519.00 | 39942.00 |
Financials (₹ Cr)
| Period | Revenue | PAT | EBITDA | Net Worth |
|---|---|---|---|---|
| 31 Mar 2026 | 1455.17 | 164.14 | 328.24 | 1144.68 |
| 31 Mar 2025 | 1027.94 | 138.58 | 256.64 | 952.95 |
| 31 Mar 2024 | 840.66 | 83.54 | 185.09 | 807.94 |
Key Ratios
Return on Equity
15.59
Return on Capital Employed
17.55
Return on Net Worth
14.55
PAT / Revenue
11.28
EBITDA / Revenue
22.56
EPS Pre-Issue
14.56
EPS Post-Issue
14.24
P/E Pre-Issue
55.43
P/E Post-Issue
56.67
Objects of the Issue
- Funding capital expenditure towards the setting up of infrastructure for research and development facility, Center of Excellence and connected office space. — ₹125.12 Cr
- Funding capital expenditure towards the purchase of certain plant, machinery and other equipment for Goa Unit I, Goa Unit II and Visakhapatnam Unit, and — ₹80.81 Cr
- General Corporate Purposes
Lead Managers
Kotak Mahindra Capital Co.Ltd.
IIFL Capital Services Ltd
Jefferies India Pvt.Ltd
Motilal Oswal Investment Advisors Ltd
Compare GMP Across IPOs
See how this IPO's GMP stacks up against every other live IPO.
Open GMP Charts →